Atjaunināt sīkdatņu piekrišanu

E-grāmata: Medicinal Plants in the Asia Pacific for Zoonotic Pandemics, Volume 3: Family Bixaceae to Portulacaceae

(University of Malaysia, Sabah)
  • Formāts - PDF+DRM
  • Cena: 131,49 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

Medicinal Plants in the Asia Pacific for Zoonotic Pandemics provides an unprecedented, comprehensive overview of the phylogeny, botany, ethnopharmacology, and pharmacology of more than 100 plants used in the traditional systems of Asia and Pacific medicine for the treatment of microbial infections. It discusses their actions and potentials against viruses, bacteria, and fungi that represent a threat of epidemic and pandemic diseases, with an emphasis on the molecular basis and cellular pathways.

This book presents for each plant the scientific name, the botanical classification, traditional medicinal uses, active chemical constituents, and pharmacology. This volume is a critical reference for anyone involved in the discovery of leads for the development of lead molecules or phytopharmaceutical products for the prevention or treatment of pandemic viral, bacterial, or fungal infections.

FEATURES











Includes phylogenetic presentation of medicinal plants and a chemotaxonomical rationale of antiviral, antibacterial, and antifungal actions





Discusses chemical structureactivity relationship, pharmacokinetics, and oral bioavailability of antimicrobial principles





Introduces the molecular mechanism of natural products on viruses, bacteria, and fungi





Contains a selection of botanical plates and useful bibliographic references

This book is a useful research tool for postgraduates, academics, and the pharmaceutical, herbal, and nutrition industries. Medicinal Plants in the Asia Pacific for Zoonotic Pandemics includes commentary sections that invite further research and reflection on the fascinating and timely subject of the development of leads or herbals from Asia-Pacific medicinal plants to safeguard humanity against the forthcoming waves of viral, bacterial, or fungal pandemics. This book is an ideal reference text for medicinal plant enthusiasts.

Recenzijas

We live in a time where the prevalence of zoonotic pandemics has a significant impact on various aspects of our livelihoods. Zoonoses in this sense are diseases transmissible between animals and humans, where the prominent risk factors include animal slaughter, handling and preparing food of animal origin, and particularly the consumption of such food when raw or undercooked. Not just in terms of health and well-being, the "side effects" of these detrimental periods zoonotic pandemics have a bearing on socioeconomic aspects too. For instance, as a result of the current COVID-19 outbreak, schools and other academic institutes have resorted to online teaching and learning; e-commerce has reigned supreme during periods of lockdown. According to the joint statement by ILO, FAO, IFAD, and WHO, the pandemic has been affecting the entire food system and has laid bare its fragility. Border closures, trade restrictions and confinement measures have been preventing farmers from accessing markets, including for buying inputs and selling their produce, and agricultural workers from harvesting crops, thus disrupting domestic and international food supply chains and reducing access to healthy, safe and diverse diets. The pandemic has decimated jobs and placed millions of livelihoods at risk. As breadwinners lose jobs, fall ill and die, the food security and nutrition of millions of women and men are under threat, with those in low-income countries, particularly the most marginalized populations, which include small-scale farmers and indigenous peoples, being hardest hit. Given these dire straits, there is a whiff of haste and acceleration in the air to find a cure and go back to how things were before the pandemic, rather than settling down under what is referred to as "new normal". The question always plays at the back of any mind investigating the "new normal" whether the periods where there were no pandemics were minor phases of abnormalities. For instance, a worldwide analysis of pathogenic diseases done from 1940 to 2004 shows that 60.3% of diseases were zoonotic and have spread vigorously. How we have dealt with the recent outbreaks of zoonotic diseases of viral origin [ i.e. severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), yellow fever, West Nile, dengue, Zika, Chikungunya, and Ebola)] demonstrates a tell-tale sign of human interaction (or rather, destruction) with wildlife and natural habitats, preserving terrestrial ecosystems and biodiversity, and overhauling food production. It would only seem logical to seek a remedy for zoonotic pandemics from nature itself to be specific, from medicinal plants. Ethnopharmacological evidence suggests that human beings have dealt with zoonotic diseases by relying on herbs and their potency to combat viral and bacterial infections in particular, of animal origin. Over the past decade or so nevertheless, the health of humans and animals has been threatened by increasing resistance to antibiotics, environmental pollution, and a higher likelihood of developing chronic diseases. Together with this trend, the interest in phytotherapy has increased because of the observed decline in the field of antibiotic research and increased concerns about the spread of antibiotic resistance. It is without a doubt that plants are rich in bioactive substances that have displayed and proven protective effects against harmful microorganisms. This is the very reason as to why they are being extensively researched as promising materials that can be used in the development of antibiotics and alternative medicines for zoonotic diseases. On the other hand, almost all of the traditional medicinal systems are based on holistic principles, which treat the human body as a whole rather than in fragmented mechanisms. Therefore, traditional herbal treatments target toward boosting immunity rather than extermination of zoonotic pathogens. The ancient traditional herbal system of medicines is maintained in many countries due to the easy availability of medicinal plants. The use of traditional medicinal plants is widely spread in China, India, Japan, Pakistan, Sri Lanka, and Thailand, and this is very much the case when it comes to zoonotic diseases. China alone accounts for approximately 40% of total herbal medicinal consumption for zoonotic diseases. Treatment with herbal drugs is easily available and cost-effective for many developing countries. It is worthwhile to mention that xiv Foreword herbal drugs are the best and most affordable way to overcome infectious diseases for these countries. From the perspective of side effects associated with synthetic drugs, herbal drugs represent a better placement of human diseases. It is heartening to usher in this four-part volume by Prof. Christophe Wiart, introducing indepth content on zoonotic diseases and the herbal remedies on offer from the Asia Pacific region. It is a timely initiative and it is without a doubt that volume 3 would garner a readership of not just scientists, researchers, and academics but also a lay audience who would be curious as a whole about alternative remedies for zoonotic diseases. It is hoped that the book would not just serve as an introduction to the plethora of medicinal plants of the Asia Pacific region, their specific mechanisms of action, bioactive compounds but also an update to any existing knowledge on the herbs covered in this volume. There is a place and time for everything, and there would be no objections in considering the current times as most suitable of all to launch an almanac containing valuable information, which would be of value to combat the health issues and challenges of modern times.



Dr. Viduranga Y. Waisundara We live in a time where the prevalence of zoonotic pandemics has a significant impact on various aspects of our livelihoods. Zoonoses in this sense are diseases transmissible between animals and humans, where the prominent risk factors include animal slaughter, handling and preparing food of animal origin, and particularly the consumption of such food when raw or undercooked. Not just in terms of health and well-being, the "side effects" of these detrimental periods zoonotic pandemics have a bearing on socioeconomic aspects too. For instance, as a result of the current COVID-19 outbreak, schools and other academic institutes have resorted to online teaching and learning; e-commerce has reigned supreme during periods of lockdown. According to the joint statement by ILO, FAO, IFAD, and WHO, the pandemic has been affecting the entire food system and has laid bare its fragility. Border closures, trade restrictions and confinement measures have been preventing farmers from accessing markets, including for buying inputs and selling their produce, and agricultural workers from harvesting crops, thus disrupting domestic and international food supply chains and reducing access to healthy, safe and diverse diets. The pandemic has decimated jobs and placed millions of livelihoods at risk. As breadwinners lose jobs, fall ill and die, the food security and nutrition of millions of women and men are under threat, with those in low-income countries, particularly the most marginalized populations, which include small-scale farmers and indigenous peoples, being hardest hit. Given these dire straits, there is a whiff of haste and acceleration in the air to find a cure and go back to how things were before the pandemic, rather than settling down under what is referred to as "new normal". The question always plays at the back of any mind investigating the "new normal" whether the periods where there were no pandemics were minor phases of abnormalities. For instance, a worldwide analysis of pathogenic diseases done from 1940 to 2004 shows that 60.3% of diseases were zoonotic and have spread vigorously. How we have dealt with the recent outbreaks of zoonotic diseases of viral origin [ i.e. severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), yellow fever, West Nile, dengue, Zika, Chikungunya, and Ebola)] demonstrates a tell-tale sign of human interaction (or rather, destruction) with wildlife and natural habitats, preserving terrestrial ecosystems and biodiversity, and overhauling food production. It would only seem logical to seek a remedy for zoonotic pandemics from nature itself to be specific, from medicinal plants. Ethnopharmacological evidence suggests that human beings have dealt with zoonotic diseases by relying on herbs and their potency to combat viral and bacterial infections in particular, of animal origin. Over the past decade or so nevertheless, the health of humans and animals has been threatened by increasing resistance to antibiotics, environmental pollution, and a higher likelihood of developing chronic diseases. Together with this trend, the interest in phytotherapy has increased because of the observed decline in the field of antibiotic research and increased concerns about the spread of antibiotic resistance. It is without a doubt that plants are rich in bioactive substances that have displayed and proven protective effects against harmful microorganisms. This is the very reason as to why they are being extensively researched as promising materials that can be used in the development of antibiotics and alternative medicines for zoonotic diseases. On the other hand, almost all of the traditional medicinal systems are based on holistic principles, which treat the human body as a whole rather than in fragmented mechanisms. Therefore, traditional herbal treatments target toward boosting immunity rather than extermination of zoonotic pathogens. The ancient traditional herbal system of medicines is maintained in many countries due to the easy availability of medicinal plants. The use of traditional medicinal plants is widely spread in China, India, Japan, Pakistan, Sri Lanka, and Thailand, and this is very much the case when it comes to zoonotic diseases. China alone accounts for approximately 40% of total herbal medicinal consumption for zoonotic diseases. Treatment with herbal drugs is easily available and cost-effective for many developing countries. It is worthwhile to mention that xiv Foreword herbal drugs are the best and most affordable way to overcome infectious diseases for these countries. From the perspective of side effects associated with synthetic drugs, herbal drugs represent a better placement of human diseases. It is heartening to usher in this four-part volume by Prof. Christophe Wiart, introducing indepth content on zoonotic diseases and the herbal remedies on offer from the Asia Pacific region. It is a timely initiative and it is without a doubt that volume 3 would garner a readership of not just scientists, researchers, and academics but also a lay audience who would be curious as a whole about alternative remedies for zoonotic diseases. It is hoped that the book would not just serve as an introduction to the plethora of medicinal plants of the Asia Pacific region, their specific mechanisms of action, bioactive compounds but also an update to any existing knowledge on the herbs covered in this volume. There is a place and time for everything, and there would be no objections in considering the current times as most suitable of all to launch an almanac containing valuable information, which would be of value to combat the health issues and challenges of modern times.



Dr. Viduranga Y. Waisundara

Foreword xiii
Preface xv
Author xvii
8.4 Order Malvales Juss. ex Bercht. & J. Presl (1820)
1(56)
8.4.1 Family Bixaceae Kunth (1822)
1(1)
8.4.1.1 BixaorellanaL
1(1)
8.4.2 Family Bombaeaeeae Kunth (1822)
2(1)
8.4.2.1 Adansonia digitata L
2(2)
8.4.2.2 Bombax cejba L
4(2)
8.4.2.3 Ceiba pentandra (L.) Gaertn
6(1)
8.4.3 Family Dipteroearpaeeae Blume (1825)
7(1)
8.4.3.1 Dipterocarpus turbinatus Gaertn
7(1)
8.4.3.2 Dryobalanops aromatica C.F. Gaertn
8(2)
8.4.3.3 Shorea robusta Gaertn
10(1)
8.4.3.4 Vatiea lanceifolia (J. Roxb.) Blume
11(2)
8.4.4 Family Malvaceae A.L. de Jussieu (1789)
13(1)
8.4.4.1 Abelmosehus manihot (L.) Medik
13(1)
8.4.4.2 Abelmosehus moschatus Medik
14(2)
8.4.4.3 Abutilon indicum (L.) Sweet
16(2)
8.4.4.4 Abutilon theophrasti Medik
18(1)
8.4.4.5 Althaea officinalis L
19(2)
8.4.4.6 Gossypium arboreum L
21(2)
8.4.4.7 Hibiscus rosa-sinensis L
23(1)
8.4.4.8 Hibiscus sabdariffa L
24(2)
8.4.4.9 Malva verticillata L
26(1)
8.4.4.10 Malvastrum eoromandelianum (L.) Garcke
26(3)
8.4.4.11 Pavonia zeylanica (L.) Cav
29(1)
8.4.4.12 Sida acuta Burm. f
29(2)
8.4.4.13 Thespesia populnea (L.) Soland ex Correa
31(2)
8.4.4.14 UrenalobataL
33(1)
8.4.5 Family Muntingiaceae C. Bayer. M. W. Chase & M. F. Fay (1998)
34(1)
8.4.5.1 Munlingia calabura L
34(1)
8.4.6 Family Sterculiaceae Ventenat (1807)
35(1)
8.4.6.1 Abroma augusta (L.) L. f
35(2)
8.4.6.2 Firmiana simplex (L.) W. Wight
37(1)
8.4.6.3 Helicteres angustifolia L
37(2)
8.4.6.4 Heritiera littoralis Aiton
39(1)
8.4.6.5 Leptonychia caudata (Wall, ex G. Don) Burrett
40(1)
8.4.6.6 Meloehia corchorifolia L
41(2)
8.4.6.7 Scaphium macropodum Beumee ex K. Heyne
43(1)
8.4.6.8 Sterculia foetida L
44(3)
8.4.7 Family Tiliaceae A. L. de Jussieu (1789)
47(1)
8.4.7.1 Corchoropsis crenata Siebold & Zucc
47(1)
8.4.7.2 Corchorus olitorius L
47(1)
8.4.7.3 Grewia hirsuta Vahl
48(1)
8.4.7.4 Microcos paniculata L
49(1)
8.4.7.5 Triumfetta rhomboidea Jacq
50(1)
8.4.5 Family Thymeleaceae A. L. de Jussieu (1789)
51(1)
8.4.5.1 Aquilaria sinensis (Lour.) Spreng
51(1)
8.4.5.2 Stellera chamaejasme L
52(5)
8.5 Order Sapindales Juss. ex Bercht. & J. Presl (1820)
57(122)
8.5.1 Family Anacardiaceae R. Brown (1818)
57(1)
8.5.1.1 Anacardium occidentale L
57(2)
8.5.1.2 Dracontomelon dao (Blanco) Merr. & Rolfe
59(1)
8.5.1.3 Lannea coromandelica (Houtt.) Merr
60(1)
8.5.1.4 Mangifera indica L
61(1)
8.5.1.5 Semecarpus anacardium L.f
62(1)
8.5.1.6 Spondias dulcis Parkinson
63(1)
8.5.1.7 Spondias pinnata (L. f.) Kurz
64(5)
8.5.2 Family Burseraceae Kunth (1824)
69(1)
8.5.2.1 Boswellia serrata Roxb. ex Colebr
69(2)
8.5.2.2 Canarium indicum L
71(1)
8.5.2.3 Canarium oleosum (Lamk.) Engler
71(1)
8.5.2.4 Commiphora wightii (Arn.) Bhandari
72(3)
8.4.2.5 Garuga pinnata Roxb
75(1)
8.4.2.6 Protium javanicum Burm.f
76(1)
8.5.3 Family Meliaceae A. L. de Jussieu (1789)
76(1)
8.5.3.1 Aglaia edulis (Roxb.) Wall
77(3)
8.5.3.2 Amoora rohituka (Roxb.) Wight & Arn
80(2)
8.5.3.3 Azadirachta indica L
82(4)
8.5.3.4 Chisocheton penduliflorus Planch, ex Hiern
86(1)
8.5.3.5 Chukrasia tabularis A. Juss
87(1)
8.5.3.6 Dysoxylum alliaceum (Blume) Blume
88(2)
8.5.3.7 Lansium domesticum Correa
90(3)
8.5.3.8 Melia azedarach L
93(5)
8.5.3.9 Sandoricum koetjape (Burm. f.) Merr
98(2)
8.5.3.10 Swietenia mahagoni (L.) Jacq
100(2)
8.5.3.11 Toona sureni (Bl.) Merr
102(3)
8.5.3.12 Xylocarpus granatum Koenig
105(2)
8.5.3.13 Xylocarpus moluccensis (Lam.) Roem
107(1)
8.5.4 Family Rutaceae A.L. de Jussieu (1789)
108(1)
8.5.4.1 Aegle marmelos (L.) Correa
108(3)
8.5.4.2 Boenninghausenia albiflora (Hook.) Rchb. ex Meisn
111(2)
8.5.4.3 Citrus sinensis (L.) Osbeck
113(9)
8.5.4.4 Clausena excavata Burm. f
122(4)
8.5.4.5 Dictamnus albus L
126(4)
8.5.4.6 Euodia hortensis J.R. Forst. & G. Forst
130(3)
8.5.4.7 Feronia elephantum Correa
133(2)
8.5.4.8 Glycosmis pentaphylla (Retz.) DC
135(2)
8.5.4.9 Melicope bonwickii (F. Muell.) T.G. Hartley
137(3)
8.5.4.10 Murraya paniculata (L.) Jack
140(3)
8.5.4.11 Ruta angustifolia (L.) Pers
143(3)
8.5.4.12 Toddalia asiatica (L.) Lam
146(4)
8.5.4.13 Zanthoxylum piperitum (L.) DC
150(4)
8.5.5 Family Sapindaceae A.L. de Jussieu (1789)
154(1)
8.5.5.1 Acer truncatum Bunge
154(2)
8.5.5.2 Allophylus eobbe (L.) Forsyth f
156(1)
8.5.5.3 Cardiospermum halicacabum L
156(3)
8.5.5.4 Dimocarpus longan Lour
159(2)
8.5.5.5 Dodonaea viscosa Jacq
161(1)
8.5.5.6 Lepisanthes rubiginosa (Roxb.) Leenh
162(1)
8.5.5.7 Harpullia petiolaris Radlk
163(1)
8.5.5.8 Nephelium mutabile Bl
164(1)
8.5.5.9 Schleiehera trijuga Willd
165(5)
8.5.6 Family Simaroubaceae A. P. de Candolle (1811)
170(1)
8.5.6.1 Ailanthus exeelsus Roxb
170(3)
8.5.6.2 Brucea javanica (L.) Merr
173(1)
8.5.6.3 Eurycoma longilblia Jack
174(2)
8.5.6.4 Picrasma javanica Bl
176(1)
8.5.6.5 Quassia indica (Gaertn.) Noot
177(2)
8.6 Order Santalales R. Br. ex Bercht. & J. Presl (1820)
179(10)
8.6.1 Family Loranthaceae A. L. de Jussieu (1808)
179(1)
8.6.1.1 Dendrophthoe pentandra (L.) Miq
179(1)
8.6.1.2 Scurrula atropurpurea (Blume) Danser
180(1)
8.6.1.3 Taxillusumbellil'er(Schult.) Danser
181(1)
8.6.2 Family Viscaceae Batseh (1802)
182(1)
8.6.2.1 Viscum articulatum Burm. F
182(1)
8.6.3 Family Olacaceae A. L. de Jussieu ex R. Brown (1818)
183(1)
8.6.3.1 Scorodocarpus borneensis Beec
183(2)
8.6.4 Family Santalaeeae R. Brown 1810
185(1)
8.6.4.1 Dendrotrophe umbellata (Blume) Miq
185(1)
8.6.4.2 Santalum album L
186(1)
8.6.4.3 Thesium ehinense Turcz
187(2)
8.7 Order Caryophyllales Juss. ex Bercht. & J. Presl (1820)
189(82)
8.7.1 Family Amaranthaceae A. L. de Jussieu (1789)
189(1)
8.7.1.1 Achyranthes aspera L
189(1)
8.7.1.2 Achyranthes ferruginea Roxb
190(1)
8.7.1.3 Aerva javanica (Burm. f.) Juss
191(1)
8.7.1.4 Aerva lanata (L.) A. L. Juss. ex Sehultes
192(1)
8.7.1.5 Aerva sanguinolenta (L.) Blume
193(1)
8.7.1.6 Amaranthus blitum L
194(1)
8.7.1.7 Amaranthus gangeticus L
195(1)
8.7.1.8 Amaranthus spinosus L
195(1)
8.7.1.9 Alternanlhera philoxeroides (Mart.) Griseb
196(2)
8.7.1.10 Alternanthera pungens Kunth
198(1)
8.7.1.11 Alternanthera sessilis (L.) DC
198(1)
8.7.1.12 Celosia argentea L
199(1)
8.7.1.13 Gomphrena celosioides Mart
200(1)
8.7.2 Family Aizoaceae Martinov (1820)
201(1)
8.7.2.1 Sesuvium portulacastrum (L.) L
202(1)
8.7.2.3 Trianthema portulacastrum L
203(1)
8.7.2.4 Zaleya pentandra (L.) C. Jeffrey
203(1)
8.7.3 Family Basellaceae Rafinesque (1837)
204(1)
8.7.3.1 Anredera cordifolia (Ten.) Steenis
205(1)
8.7.3.2 Basella alba L
206(1)
8.7.4 Family Ancistrocladaceae Planch, ex Walp. (1851)
207(1)
8.7.4.1 Ancistrocladus tectorius (Lour.) Merr
207(1)
8.7.5 Family Cactaceae A.L. de Jussieu (1789)
208(1)
8.7.5.1 Opuntia ficus-indica (L.) Mill
209(1)
8.7.6 Family Caryophyllaceae A. L. de Jussieu (1789)
210(1)
8.7.6.1 Dianthus chinensis L
210(1)
8.7.6.2 Drymaria cordata (L.) Willd. ex Schult
211(1)
8.7.6.3 Gypsophila oldhamiana Miq
212(2)
8.7.6.4 Lychnis coronaria (L.) Desr
214(1)
8.7.6.5 Spergula arvensis L
214(1)
8.7.7 Family Chenopodiaceae Ventenat (1799)
214(1)
8.7.7.1 Arthrocnemum indicum (Willd.) Moq
215(1)
8.7.7.2 Atriplex hortensis Boiss
215(2)
8.7.7.3 Chenopodium album L
217(1)
8.7.7.4 Chenopodium botrys L
218(1)
8.7.7.5 Dysphania ambrosioides (L.) Mosyakin & Clemants
218(2)
8.7.7.6 Haloxylon salicornicum (Moq.) Bunge ex Boiss
220(1)
8.7.7.7 Kochia scoparia (L.) Schrad
221(1)
8.7.7.8 Suaeda maritima (L.) Dumort
222(1)
8.7.8 Family Droseraceae R. A Salisbury (1808)
223(1)
8.7.8.1 Drosera burmannii Vahl
224(1)
8.7.8.2 Drosera peltata Thunb
224(2)
8.7.9 Family Molluginaceae Bartling (1825)
226(1)
8.7.9.1 Glinus oppositifolius (L.) Aug. DC
226(1)
8.7.9.2 Mollugo pentaphylla L
227(1)
8.7.9.3 Mollugo nudicaulis L
228(1)
8.7.10 Family Phytolaccaceae R. Brown (1818)
229(1)
8.7.10.1 Phytolacca acinosa Roxb
229(1)
8.7.10.2 Phytolacca americana L
230(1)
8.7.11 Family Plumbaginaceae A. L. de Jussieu (1789)
230(1)
8.7.11.1 Aegialitis rotundifolia Roxb
231(1)
8.7.11.2 Limonium sinense (Girard) Kuntze
231(1)
8.7.11.3 Plumbago indica L
232(2)
8.7.11.4 Plumbago zeylanica L
234(1)
8.7.12 Family Polygonaceae A.L. de Jussieu (1789)
235(1)
8.7.12.1 Fagopyrum esculentum Moench
236(1)
8.7.12.2 Homalocladium platycladum (F.J. Muell.) L.H. Bailey
237(2)
8.7.12.3 Persicaria barbata (L.) H. Hara
239(1)
8.7.12.4 Persicaria hydropiper (L.) Delarbre
239(2)
8.7.12.5 Persicaria perfoliata H. Gross
241(1)
8.7.12.6 Polygonum aviculare L
242(1)
8.7.12.7 Polygonum bistorta L
243(1)
8.7.12.8 Polygonum capitatum Buch.-Ham. ex D. Don
244(1)
8.7.12.9 Polygonum cuspidatum Siebold & Zucc
245(5)
8.7.12.10 Polygonum dichotomum Bl
250(1)
8.7.12.11 Polygonum equisetiformc Sibth. & Sm
250(1)
8.7.12.12 Polygonum glabrum Willd
250(2)
8.7.12.13 Polygonum orientale L
252(1)
8.7.12.14 Polygonum plcbcium R. Br
253(1)
8.7.12.15 Polygonum viscosum Buch.-Ham. ex D. Don
253(2)
8.7.12.16 Rheum australe D. Don
255(1)
8.7.12.17 Rheum officinale Baills
256(2)
8.7.12.18 Rheum palmalum L
258(1)
8.7.12.19 Rheum ribes L
259(1)
8.7.12.20 Rumex aeetosa L
260(2)
8.7.12.21 Rumex aquaticus L
262(1)
8.7.12.22 Rumex crispus L
263(1)
8.7.12.23 Rumex dentatus L
264(1)
8.7.12.24 Rumex japonicus Houtt
265(1)
8.7.12.25 Rumex nepalensis Spreng
266(2)
8.7.12.26 Rumex palientia L
268(1)
8.7.13 Family Portulacaceae A. L. de Jussieu (1789)
269(1)
8.7.13.1 Portulaca oleracea L
269(2)
Bibliography 271(8)
Index 279
Christophe Wiart is a French scientist. His fields of expertise are Asian ethnopharmacology, chemotaxonomy and ethnobotany. He has collected, identified and classified several hundred species of medicinal plants from India, Southeast Asia and China. Ethnopharmacology of medicinal plants in Asia Pacific; bioprospection, collection and identification of medicinal botanical samples and phytochemical and pharmacological study for the identification of lead compounds as novel antibacterial, anticancer, and antioxidant principles from rare plants from the rainforest of Southeast Asia. Dr. Christophe Wiart appeared on HBO's Vice (TV Series) in season 3, episode 6 (episode 28 of the series), titled "The Post-Antibiotic World & Indonesia's Palm Bomb." This episode aired on April 17, 2015. It highlighted the need to find new treatments for infections that were previously treatable with antibiotics, but are now resistant to multiple drugs. "The last hope for the human races survival, I believe, is in the rainforests of tropical Asia", said ethnopharmacologist Dr. Christophe Wiart. "The pharmaceutical wealth of this land is immense".